Business Description
Dr. Martens PLC
ISIN : GB00BL6NGV24
Share Class Description:
LSE:DOCS: Ordinary SharesCompare
Compare
Traded in other countries / regions
DOCS.UKDOCMF.USA3U2.GermanyDOCS.Mexico IPO Date
2021-01-29Description
Dr. Martens PLC is engaged in the business of footwear. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. Geographically, it derives a majority of revenue from EMEA and also has a presence in the Americas and APAC.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 1.34 | |||||
| Debt-to-EBITDA | 3.19 | |||||
| Interest Coverage | 2.36 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5 | |||||
| Beneish M-Score | -3.27 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.8 | |||||
| 3-Year EBITDA Growth Rate | 11.6 | |||||
| 3-Year EPS without NRI Growth Rate | -15.3 | |||||
| 3-Year Book Growth Rate | 36.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.84 | |||||
| 9-Day RSI | 56.57 | |||||
| 14-Day RSI | 61.53 | |||||
| 6-1 Month Momentum % | -28.02 | |||||
| 12-1 Month Momentum % | -37.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.26 | |||||
| Quick Ratio | 0.99 | |||||
| Cash Ratio | 0.49 | |||||
| Days Inventory | 356.59 | |||||
| Days Sales Outstanding | 40.11 | |||||
| Days Payable | 127.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.44 | |||||
| Dividend Payout Ratio | 0.68 | |||||
| Forward Dividend Yield % | 2.48 | |||||
| 5-Year Yield-on-Cost % | 3.48 | |||||
| 3-Year Average Share Buyback Ratio | 1.3 | |||||
| Shareholder Yield % | 11.8 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.52 | |||||
| Operating Margin % | 8.81 | |||||
| Net Margin % | 3.65 | |||||
| FCF Margin % | 25.26 | |||||
| ROE % | 8.27 | |||||
| ROA % | 3.03 | |||||
| ROIC % | 6.98 | |||||
| ROC (Joel Greenblatt) % | 14.41 | |||||
| ROCE % | 8.7 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.57 | |||||
| Forward PE Ratio | 13.24 | |||||
| PE Ratio without NRI | 19.51 | |||||
| Price-to-Owner-Earnings | 5.58 | |||||
| PEG Ratio | 1 | |||||
| PS Ratio | 0.88 | |||||
| PB Ratio | 2.13 | |||||
| Price-to-Tangible-Book | 12.36 | |||||
| Price-to-Free-Cash-Flow | 3.51 | |||||
| Price-to-Operating-Cash-Flow | 3.17 | |||||
| EV-to-EBIT | 15.58 | |||||
| EV-to-Forward-EBIT | 7.64 | |||||
| EV-to-EBITDA | 7.58 | |||||
| EV-to-Forward-EBITDA | 6.11 | |||||
| EV-to-Revenue | 1.33 | |||||
| EV-to-Forward-Revenue | 1.24 | |||||
| EV-to-FCF | 5.21 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.54 | |||||
| Price-to-Graham-Number | 3.22 | |||||
| Earnings Yield (Greenblatt) % | 6.42 | |||||
| FCF Yield % | 28.53 | |||||
| Forward Rate of Return (Yacktman) % | 33.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dr. Martens PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 805.9 | ||
| EPS (TTM) (£) | 0.029 | ||
| Beta | 0.37 | ||
| Volatility % | 50.04 | ||
| 14-Day RSI | 61.53 | ||
| 14-Day ATR (£) | 0.042211 | ||
| 20-Day SMA (£) | 0.71385 | ||
| 12-1 Month Momentum % | -37.19 | ||
| 52-Week Range (£) | 0.4932 - 1 | ||
| Shares Outstanding (Mil) | 962.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dr. Martens PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dr. Martens PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dr. Martens PLC Frequently Asked Questions
What is Dr. Martens PLC(LSE:DOCS)'s stock price today?
The current price of LSE:DOCS is £0.74. The 52 week high of LSE:DOCS is £1.00 and 52 week low is £0.49.
When is next earnings date of Dr. Martens PLC(LSE:DOCS)?
The next earnings date of Dr. Martens PLC(LSE:DOCS) is 2025-05-30 Est..
Does Dr. Martens PLC(LSE:DOCS) pay dividends? If so, how much?
The Dividend Yield %  of Dr. Martens PLC(LSE:DOCS) is 3.44% (As of Today), Highest Dividend Payout Ratio of Dr. Martens PLC(LSE:DOCS) was 0.83. The lowest was 0.07. And the median was 0.45. The  Forward Dividend Yield % of Dr. Martens PLC(LSE:DOCS) is 2.48%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers